BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6392688)

  • 21. Epoprostenol for primary pulmonary hypertension.
    Med Lett Drugs Ther; 1996 Feb; 38(968):14-5. PubMed ID: 8592477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.
    Krowka MJ; Frantz RP; McGoon MD; Severson C; Plevak DJ; Wiesner RH
    Hepatology; 1999 Sep; 30(3):641-8. PubMed ID: 10462369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children.
    Ichida F; Uese K; Hashimoto I; Hamamichi Y; Tsubata S; Fukahara K; Murakami A; Miyawaki T
    J Cardiol; 1997 Apr; 29(4):217-24. PubMed ID: 9127838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of pimobendan on pulmonary hypertension in patients with chronic pulmonary emphysema].
    Yamazaki Y; Matsumoto H; Takeda A; Takahashi T; Sasaki N; Takahashi M; Tsuji T; Fujikane T; Shimizu T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Aug; 35(8):847-53. PubMed ID: 9366158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of the preparation CIBA 31 531-Ba on respiration and pulmonary circulation].
    Jedlicka K; Daum S; Nikodýmová L; Stiksa J
    Cas Lek Cesk; 1969 May; 108(21):629-33. PubMed ID: 5788079
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of primary pulmonary hypertension with phentolamine].
    Heinrich U; Angehrn W; Steinbrunn W
    Schweiz Med Wochenschr; 1983 Jan; 113(4):145-8. PubMed ID: 6828847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled nitric oxide for perioperative management of an adult patient with atrial septal defect and severe pulmonary hypertension.
    Kim JH; Ham BM; Kim YL; Ahn H; Noh CI
    J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):746-8. PubMed ID: 12486659
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.
    Mogollón Jiménez MV; Escoresca Ortega AM; Hinojosa Pérez R; Lage Gallé E; Herruzo Avilés A; Sobrino Márquez M; Frutos López M; Romero Rodríguez N; Pérez de la Yglesia R; Martínez Martínez A
    Transplant Proc; 2008 Nov; 40(9):3009-11. PubMed ID: 19010174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostacycline (Flolan). Intravenous nursing responsibilities in the care of the patient with primary pulmonary hypertension.
    Benvenuto DB
    J Intraven Nurs; 1999; 22(5):267-72. PubMed ID: 10776190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of isosorbide dinitrate on the pulmonary arterial system in patients with pulmonary hypertension (author's transl)].
    Hoshino T; Handa S; Akizuki S; Hori S; Norisue H; Hori A; Fukui T
    Kokyu To Junkan; 1981 Mar; 29(3):291-5. PubMed ID: 7255981
    [No Abstract]   [Full Text] [Related]  

  • 31. [Primary pulmonary hypertension: physiopathology and critical evaluation of the therapy].
    Mazza F; Morra AM; Morra MG; Catalano M; Contiello V; Polcino A
    Clin Ter; 1989 Feb; 128(4):239-42. PubMed ID: 2524312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of acute pulmonary hypertension by prostacyclin.
    Borchert J; Franke J; Lichey J
    Cor Vasa; 1980; 22(4):281-7. PubMed ID: 7004773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Timeline of haemodynamic improvement with subcutaneous prostacyclin therapy in a patient with severe pulmonary arterial hypertension.
    Sadushi-Koliçi R; Perthold W; Fruhwald FM; Lang IM
    Eur J Clin Invest; 2008 Aug; 38(8):603-4. PubMed ID: 18573098
    [No Abstract]   [Full Text] [Related]  

  • 34. Managing patients with primary pulmonary hypertension: prostacyclin therapy.
    Albert NM; Hague K
    Am J Crit Care; 1997 Jul; 6(4):274-80. PubMed ID: 9215424
    [No Abstract]   [Full Text] [Related]  

  • 35. Sildenafil for pulmonary hypertension.
    Lee AJ; Chiao TB; Tsang MP
    Ann Pharmacother; 2005 May; 39(5):869-84. PubMed ID: 15827074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current views on the use of vasodilators in pulmonary hypertension].
    Ceriana P; De Amici D; Pagnin A; Braschi A
    Minerva Cardioangiol; 1995 Jun; 43(6):273-9. PubMed ID: 7566540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute hemodynamic response to vasodilators in primary pulmonary hypertension.
    Kulkarni H; Srinivas A; Vora A; Kerkar P; Dalvi B
    J Postgrad Med; 1996; 42(1):7-11. PubMed ID: 9715289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5th International Symposium on Pulmonary Circulation.
    Widimský J; Herget J
    Cor Vasa; 1990; 32(3):241-50. PubMed ID: 2209027
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of vasodilators on pulmonary hypertension].
    Uotani K; Kanamori K; Fujimura M; Mifune J; Taga K; Shimizu M; Hifumi S; Takahashi Y; Azuma H; Tanaka T
    Kokyu To Junkan; 1986 Sep; 34(9):977-83. PubMed ID: 3786964
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ballistocardiography in the evaluation of pulmonary circulation and changes in the ballistocardiogram with the use of ganglionic blockaders in pulmonary tuberculosis].
    Kidanova ZS; Rumiantsev VB
    Grudn Khir; 1971; 13(1):96-100. PubMed ID: 4397036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.